Announcements Trials

Browse Landscape

Sponsor

Conditions

Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Sorafenib 52 pembrolizumab 26 Nivolumab 20 Bevacizumab 19 Radiosurgery 17 Doxorubicin 12 atezolizumab 9 Erlotinib Hydrochloride 9 lenvatinib 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 tremelimumab 6 durvalumab 6 Ramucirumab 6 Radiofrequency Ablation 6 Cisplatin 6 Sunitinib 5 tislelizumab 4 regorafenib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Fluorouracil 4 Everolimus 4 Capecitabine 4 nintedanib 3 fluoromisonidazole 3 carotuximab 3 bavituximab 3 Tomography, X-Ray Computed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × Receptor Protein-Tyrosine Kinases × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡